Peter Moesta

Advisory Board at Harbour BioMed

Peter Moesta, Ph.D., has served on the scientific advisory board since December 2016. He oversaw the development, production and worldwide launch of important medicines, such as Humira, Yervoy and Opdivo. Dr. Moesta previously served in executive roles at Bristol-Myers Squibb.

Org chart

Alexander Zukiwski

Advisory Board Member

Zhigang Tian

Advisory Board

Robert Kramer

Advisory Board

Robert Kamen

Advisory Board

Frank Grosveld

Advisory Board

Teams

+3

Board of Directors

6 members

Timeline

  • Advisory Board

    Current role